Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements

Lignende værker

• Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review
  af: Yingzhe Luo, et al.
  Udgivet: (2024-08-01)
• Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy
  af: Jingjing Su, et al.
  Udgivet: (2024-01-01)
• Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements
  af: Alejandra Martínez-Pérez, et al.
  Udgivet: (2024-11-01)
• Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
  af: Christian Sordo-Bahamonde, et al.
  Udgivet: (2023-08-01)
• Complete Response to Nivolumab‐Relatlimab Following Progression of Invasive Sinonasal Mucosal Melanoma on First‐Line Nivolumab‐Ipilimumab: A Case Report
  af: Reema Patel, et al.
  Udgivet: (2026-04-01)